Price
$105.97
Increased by +0.63%
Dollar Volume
47.78 M
ADR%
2.42
Earnings Report Date (estimate)
Jan 31, 23 (0.99)
Market Cap.
5.75 B
Shares Float
49.60 M
Shares Outstanding
54.26 M
Beta
1.00
Price / Earnings
33.12
BPR
64.29
20D Range
100.48 112.71
50D Range
100.48 114.36
200D Range
91.39 114.36
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Feb 1, 23 0.97
Decreased by -48.68%
0.99
Decreased by -2.02%
Jan 31, 23 0.97
Decreased by -35.33%
0.99
Decreased by -2.02%
Nov 8, 22 1.46
Increased by +65.91%
1.41
Increased by +3.55%
Nov 7, 22 1.46
Increased by +19.67%
1.41
Increased by +3.55%
Jul 26, 22 1.89
Increased by +54.92%
1.67
Increased by +13.17%
Apr 26, 22 1.50
Increased by +42.86%
1.36
Increased by +10.29%
Feb 1, 22 0.88
Decreased by -6.38%
0.87
Increased by +1.15%
Nov 9, 21 1.22
Increased by +23.23%
1.29
Decreased by -5.43%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 632.00 M
Increased by +94.46%
57.00 M
Increased by +29.55%
Increased by +9.02%
Decreased by -33.38%
Jun 30, 22 644.00 M
Increased by +1.10%
36.00 M
Decreased by -55.00%
Increased by +5.59%
Decreased by -55.49%
Mar 31, 22 604.00 M
Increased by +1.00%
786.00 M
Increased by +1.82 K%
Increased by +130.13%
Increased by +1.80 K%
Dec 31, 21 512.00 M
Decreased by -7.25%
48.00 M
Decreased by -14.29%
Increased by +9.38%
Decreased by -7.59%
Sep 30, 21 325.00 M
Decreased by -46.63%
44.00 M
Increased by +780.00%
Increased by +13.54%
Increased by +1.55 K%
Jun 30, 21 637.00 M
Increased by +10.98%
80.00 M
Increased by +116.22%
Increased by +12.56%
Increased by +94.83%
Mar 31, 21 598.00 M
Decreased by -1.97%
41.00 M
Increased by +107.04%
Increased by +6.86%
Increased by +107.19%
Dec 31, 20 552.00 M
Increased by +3.56%
56.00 M
Increased by +75.00%
Increased by +10.14%
Increased by +68.98%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.